Wayne State University School of Medicine, Detroit Medical Center, Detroit, Michigan.
Wayne State University School of Medicine, Detroit Medical Center, Detroit, Michigan.
Am J Cardiol. 2019 May 15;123(10):1715-1721. doi: 10.1016/j.amjcard.2019.02.033. Epub 2019 Feb 27.
In patients with severe peripheral vascular disease, the common femoral artery may be so diseased as to not allow for deployment of mechanical circulatory support (MCS) such as in the setting of cardiogenic shock (CS). We sought to study the feasibility of axillary artery as alternative access for MCS in CS patients with severe occlusive peripheral artery disease (PAD). Records of all patients who presented with CS requiring MCS through axillary artery access from January 2016 to October 2017 were examined. Demographics, clinical, procedural, and outcomes data were collected on all patients. A total of 17 patients (mean age 68 ± 14years, 95% men) were identified. This was due to severe PAD in the iliac and/or common femoral arteries prohibiting large bore sheath access in allcases. Of the 17 patients, 9 required percutaneous coronary intervention. Time from axillary access to activation of Impella was 14.8 ± 4 minutes. Three patients required concomitant Impella RP for right ventricular support due to biventricular CS. Twelve patients died before Impella was explanted due to multiorgan failure, stroke, and infection. None of the patients who died had vascular complications related to axillary access. All 5 patients who survived to Impella explant were discharged from the hospital without major complication. Axillary artery is a safe and feasible alternative access for large bore devices in patients with prohibitive PAD. The meticulous technique described assures a very low rate of access related complications.
在患有严重外周血管疾病的患者中,股总动脉可能病变严重,无法放置机械循环支持(MCS),例如在心肌梗死合并心源性休克(CS)的情况下。我们旨在研究腋动脉作为 CS 合并严重阻塞性外周动脉疾病(PAD)患者 MCS 替代入路的可行性。检查了 2016 年 1 月至 2017 年 10 月期间因 CS 需要通过腋动脉入路接受 MCS 的所有患者的记录。收集了所有患者的人口统计学、临床、手术和结局数据。共确定了 17 名患者(平均年龄 68 ± 14 岁,95%为男性)。这是因为髂动脉和/或股总动脉严重 PAD 导致所有患者均无法使用大口径鞘管入路。在 17 名患者中,9 名需要经皮冠状动脉介入治疗。腋动脉入路到 Impella 激活的时间为 14.8 ± 4 分钟。由于双心室 CS,有 3 名患者需要同时使用 Impella RP 来支持右心室。由于多器官衰竭、中风和感染,12 名患者在 Impella 被取出之前死亡。没有死亡患者因腋动脉入路而出现血管并发症。所有幸存至 Impella 取出的 5 名患者均未出现主要并发症而出院。腋动脉是一种安全且可行的方法,适用于 PAD 严重的患者,可使用大口径设备。描述的细致技术可确保非常低的血管相关并发症发生率。